C hapte r

DIABETES MELLITUS

PREDIABETES

Chapter 396 Diabetes Me/litus: Diagnosis, C/ossificoffon, and Pathophysialagy Page 2850, Chapte,
397 Diabetes Mel/itus: Management and Therapies Page 2859

1. What is Prediabetes? Mention strategies for primary prevention of Type 2

DM. (3+7) (Dec. 13)
2. Preservation of beta cell functions in diabetes.
10 (Dec. 04)
HYPOGLYCEMIA
Chapter 399 Hypoglycemia 2883

1. (a) Classify diabetes mellitus. (b) Physiological response to an episode of

hypoglycemia. 4+6 (Dec. 20)

2. Define hypoglycemia. Discuss its etiology, clinical features and diagnostic

evaluation. 1 +(3+3+3) (Dec. 12)
3
_ (a) Define hypoglycemia. (b) Enumerate the causes of hypoglycemia,
(c) Outline the management of hypoglycemia. 1+4+5 (Dec. 16)
4 _ Hypoglycemia: causes and management. (June 08)
10
GESTATIONAL DIABETES
Chapter 396 Dia e e
. b t s Me/litus: Diagnosis, Classification, and Pathophysiology Page
2850
(a) Define gestational diabetes mellitus (GDM). (b) Diagnosis and
l . complications of GDM. 2+(4+4) (Dec. 15)

What is gestational diabetes mellitus? Write down its Pathophysiology,

2. diagnostic criteria and treatment. 2+(3+2+3) (Dec.17)

ribe the diagnostic criteria and management of gestational diabetes.

3. Desc 10 (Dec. 10)

. al diabetes mellitus. . . 10 (June 07)

4. Gestation . b t s? What is its risk to foetus? How . .
. gestational d1a e e · 1s gestational
5. diabetes
What JS managed?. (2+3+SJ (Dec. 14)

Si\
/---------
Chapter 6 \ Diabetes Me\\itus { 31 \
. 10 (D
. Gestat'·onal diabetes melhtus. ec. 04)
6
oe ·ne gestational diabetes.
. Enumerate its risks to foetus • Oescn.be .its
f'
7. rnanagement strategies. 2+3+5 (June 12)

ft\AT~ SET OlABmS OF YOUNG

chapter 6 Diabetes Mellitus: Diagnosis, Classification, and Pathophysio/ogy Page 2850
39
1. Maturity onset diabetes of young. 5 (Dec. 17)

DERMATOLOGICAL MANIFESTATIONS OF DIABETES MELLITUS

chapter 398 Diabetes Mellitus: Complications Page 2875

1. Dermatological manifestations of diabetes mellitus. 10 (June 09)

i'
~ LINS
Chapter 397 Diabetes Mellitus: Management and Therapies Page 2859
10 (June 09)
1. Newer insulins.
10 (June 06)
2. Newer insulin analogues.
10 (Dec. 07)
3. Insulin analogues.
10 (Dec. 05)
4. Insulin resistance.
(? l ll

~ORALANTI-DIABETIC DRUGS
Chapter 397 Diabetes Mellitus: Management and Therapies Page 2859

1. Classify glucose lowering therapies used in type 2 diabetes mellitus and

1
their therapeutic use in regimens. 0 (Dec. OBJ
nd
2. What are incretins? Describe its physiological basis of treatment, a
·· · · · 10 (June 11)
spec1f1c md1cat1ons for use. • · f action and specific
3. ':Nh_at are Gliptins? Describe their mechanism o (2+4+4) (Dec. 11)
indications of usage.
·on, clinical uses and adverse effec3t+s4+o3f
Of actl
4. Outline the mechanism
metformin. . d rnical •
uses of mettormm.
1
5. (a) Discuss the mechanism of action an c 5+5 (Dec. 20)
. ·tating factors clinical features,
6. (a) Newer anti-diabetic drugs . t(~~ :yrep~~~lycemic hyp~rosmolar state;,
laboratory findings and treatmen 4+(1 +1 +2+2) (Dec. 20191
. mellitus. (b) Treatme~t ~oal~ in
athogenesis of Type 2 d1abet~s . chanism of action, md1cat1ons
7. (a) p 'th diabetes mellitus. (c) lncretms. me 3+3+4 (June 16)
adu\tsadverse
w1 effects. _ _ _ _ _ _ _ __ __
d
 [ 32 ] Medicine I DNB Topic-wise Questi~n Bank

8. Write short notes on : lncretin physiology. How can we use it . . '

situations? ---------
~0 chnicai
1
9. GLP-1- Physiological role and therapeutics.
. (D 14)
(June
10
.
10. Glycemic control and complications: . rn
trials . diabetes
. mellitus. (J
ec. 08)
10
une o7;
DIABETIC NEPHROPATHY

Chapter 398 Diabetes Mel/itus: Complications Page 2875

1. Microalbuminuria: definition and clinical implications. 10 (June De)

2. Pathogenesis, natural history and management of diabetic nephropathy_

3+3+4 (June 15)
3. Diabetic nephropathy.
10 (Dec. 06)
4. Diabetic nephropathy.
10 (June 07)
DIABETIC FOOT

Chapter 398 Diabetes Mellitus: Complications Page 2875

1. Diabetic foot.
10 (June 06)
DIABETIC KETOACIDOSIS
Chapter 398 Diabetes Mel/itus: Complications Page 2875

1. (a) Glycaemic variability and its clinical relevance, (b) Diagnosis &
treatment of diabetic ketoacidosis and monitoring while treating.
4+(2+2+2) (June 18)
2
_ Clinical features, diagnostic tests and treatment of diabetic ketoacidosis.

3+3+4 (Dec. 15)

3. Diagnosis and principles of management of DKA.
10 (June 06)
4. How do ketone bodies formd_inboutr bodyd?. Hotw do~s their excess production
overhelm our system in ,a e es an s arvat,on to produce ketosis?

5+(3+2) (June 14}

HYPEROSMOLAR NONKETOTIC DIABETIC COMA
Chapter 398 Diabetes Mel/itus: Complications Page. 2875

ketotic diabetic coma.

l . Hyperosmolar non t fh 10 (Dec. 06)
2 Clinical features, diagnosis and managemen o YPerosrnolar non ketotic
· coma. 3 +3 +4 Oune 2 0)